We have updated our terms and conditions and privacy policy Click "Continue" to accept and continue with ET HealthWorld

Dear user, ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website. You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website. If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET HealthWorld.

Monkeypox: Kerala steps up vigil, issues special alerts to 5 districts7 hrs ago

Nasal spray lowers Covid viral load by 94 per cent in 24 hours: Lancet study16 hrs ago

The unsung hero in faster holistic recovery

Technological Disruption in Indian Health & Pharma

Do you think you are up for the challenge?

Holistic Solutions For A Healthier India

The Indian space agency will soon transfer the technology for making the 'Shwaas', the oxygen concentrator developed by it at a cost of about Rs 60,000 to industries, said a top official of Vikram Sarabhai Space Centre (VSSC).

125000+ Industry Leaders read it everyday

The growing anti-diabetes market, valued at about Rs 17,000 crore, is set to witness action with generic versions of US firm Merck’s blockbuster Januvia being launched, reducing the cost of therapy by a third. This is on the heels of Sitagliptin, a relatively newer but vital anti-diabetic drug, losing patent protection in July.

The use of antacids, which can cause irregular heartbeats and plaque buildup in the arteries, increases the risk of developing cardiovascular diseases in people with GERD.

We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.

Please contact us to know more details.

Get ETHealthworld 's top stories every morning in your email inbox.

125000+ Industry Leaders read it everyday

Follow @ETHealthworld for the latest news, insider access to events and more.